LeonaBio, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
LONA on Nasdaq
Location
Bothell, WA
Fiscal year end
31 December
Latest financial report
31 Mar 2026

Quick Takeaways

  • LONA - LeonaBio, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity -291%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+163%</span>.
  • Most recent SEC facts end date: 31 Dec 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-12-31) highlights Return On Equity -290.8%, Return On Assets -139.9%, and Current Ratio 1.88x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

26.3/100

Weak Confidence low

Return On Equity

-291%

Metric score 0.0/100

Return On Assets

-140%

Metric score 0.0/100

Financial Health

Current Ratio
1.88x

Strengths

Current Ratio

Watchpoints

Return On Equity, Return On Assets, and NetIncomeLoss YoY

Key metrics snapshot

Return On Equity

-291%

YoY: +163%

Industry median: -47% (n=218)

View history

Return On Assets

-140%

YoY: +58%

Industry median: -44% (n=217)

View history

Current Ratio

1.88x

YoY: -55%

Industry median: 3.67x (n=218)

View history

NetIncomeLoss YoY

-8.9%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -291% +163%
Return On Assets -140% +58%

Financial Health

Metric Latest value YoY change
Current Ratio 1.88x -55%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -8.9%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 3,943,887 -90%
Common Stock, Shares, Outstanding 9,335,913 +139%
Common Stock, Value, Issued $1,000
Weighted Average Number of Shares Outstanding, Basic 4,275,762 +11%
Weighted Average Number of Shares Outstanding, Diluted 4,275,762 +11%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $17,500,000 -75%
General and Administrative Expense $16,678,000 -36%
Costs and Expenses $102,266,000 +1.4%
Operating Income (Loss) $102,266,000 -1.4%
Earnings Per Share, Basic -24.7 +1.9%
Earnings Per Share, Diluted -24.7 +1.9%
Cash and Cash Equivalents, at Carrying Value $69,276,000 +43%
Assets, Current $89,458,000 +63%
Property, Plant and Equipment, Net $1,472,000 -40%
Operating Lease, Right-of-Use Asset $535,000 -34%
Other Assets, Noncurrent $55,000 0%
Assets $92,151,000 +57%
Accounts Payable, Current $4,587,000 +1338%
Employee-related Liabilities, Current $1,948,000 -35%
Accrued Liabilities, Current $4,963,000 -60%
Liabilities, Current $47,503,000 +262%
Operating Lease, Liability, Noncurrent $338,000 -58%
Other Liabilities, Noncurrent $1,404,000
Liabilities $64,361,000 +362%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,000 -500%
Retained Earnings (Accumulated Deficit) $511,755,000 -26%
Stockholders' Equity Attributable to Parent $27,790,000 -38%
Liabilities and Equity $92,151,000 +57%
Common Stock, Shares Authorized 90,000,000 0%
Common Stock, Shares, Issued 9,335,913 +139%
Common Stock, Par or Stated Value Per Share 0.0001 0%
Deferred Tax Assets, Valuation Allowance $112,623,000 +22%
Deferred Tax Assets, Gross $112,864,000 +22%
Operating Lease, Liability $803,000 -34%
Depreciation $972,000 +0.21%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $105,614,000 -9.3%
Lessee, Operating Lease, Liability, to be Paid $855,000 -37%
Property, Plant and Equipment, Gross $5,739,000 0%
Operating Lease, Liability, Current $465,000 +12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $346,000 -32%
Lessee, Operating Lease, Liability, to be Paid, Year One $509,000 +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.081 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $52,000 -61%
Deferred Tax Assets, Operating Loss Carryforwards $56,887,000 +31%
Unrecognized Tax Benefits $4,311,000 +4.6%
Share-based Payment Arrangement, Expense $6,102,000 -45%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY